Analytical Review of Northwest Biotherapeutics, Inc. (NYSE:NWBO)

124

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Northwest Biotherapeutics, Inc. (NYSE:NWBO) for the period of 9-Day stands at 29.49% while the stochastic %D for the same period stands at 26.73%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Northwest Biotherapeutics, Inc. (NYSE:NWBO) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for Northwest Biotherapeutics, Inc. (NYSE:NWBO) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently Northwest Biotherapeutics, Inc. (NYSE:NWBO)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.

Previous Day Activity Analysis

On the last trading day, Northwest Biotherapeutics, Inc. (NYSE:NWBO) opened the session at $0.163 and after going up 0.9% closed at $0.17. The stock gained 0.01 points in the last trade.

Northwest Biotherapeutics, Inc. (NYSE:NWBO)’s stock fluctuated in the range of $0.162 and $0.175 during the previous active session. Northwest Biotherapeutics, Inc. (NYSE:NWBO) traded with the volume of 1.14 Million with average volume of 1.77 Million. The stock has LOW volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.01 and 44.77 respectively.

Currently the Insider Ownership of the shares of Northwest Biotherapeutics, Inc. (NYSE:NWBO) is at 30.22% and the shares outstanding are 216.94 Million.

Important Ratio Analysis

Some important ratios to consider here for Northwest Biotherapeutics, Inc. (NYSE:NWBO) are discussed below:

Dividend yield of Northwest Biotherapeutics, Inc. (NYSE:NWBO) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 79.86 and 0 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 0 and 0 correspondingly.

The Quick Ratio of Northwest Biotherapeutics, Inc. (NYSE:NWBO) stands at 0 while the Current Ratio depicts the value of 0.

Return on Assets ROA of Northwest Biotherapeutics, Inc. (NYSE:NWBO) is at 0% whereas, Return on Equity ROE and Return of Investment ROI of Northwest Biotherapeutics, Inc. (NYSE:NWBO) stand at 0% and 0% respectively.

Stock Performance Analysis

The stock performance of Northwest Biotherapeutics, Inc. (NYSE:NWBO) on the basis of 5 day trade show the dip of -0.48% whereas, the monthly performance of the stock shows decrease of -8.97%.

The quarterly performance of the stock remained in green zone with the value of 0% while six month performance of the shares of Northwest Biotherapeutics, Inc. (NYSE:NWBO) remained bullish with the count of 0%.

The yearly and YTD performance of Northwest Biotherapeutics, Inc. (NYSE:NWBO) remained mix at 0% and -15.83% respectively.